[
  {
    "ts": null,
    "headline": "Glenview, Sachem Head, Third Point buy CVS shares during Q3-filings",
    "summary": "Three prominent investment firms bet changes are in the offing at ailing healthcare giant CVS Health and added to existing bets and established a new position during the third quarter, according to regulatory filings.  Longtime investor Glenview Capital Management bought 2.8 million CVS shares during the third quarter, increasing its stake by 31%.  Sachem Head Capital Management, which built its CVS position during the second quarter, bought over 1 million shares during the three months ended on Sept. 30, increasing its position by 44%.",
    "url": "https://finnhub.io/api/news?id=c15ccfae87708e4c82ca840904059eaa30f03dbdf3e441738fb17e7e7a9be6b1",
    "source": "Yahoo",
    "provider": "finnhub",
    "raw": {
      "category": "company",
      "datetime": 1731626631,
      "headline": "Glenview, Sachem Head, Third Point buy CVS shares during Q3-filings",
      "id": 131362437,
      "image": "https://media.zenfs.com/en/reuters.com/7200e106bff5ace130dd0f8e5411d627",
      "related": "CVS",
      "source": "Yahoo",
      "summary": "Three prominent investment firms bet changes are in the offing at ailing healthcare giant CVS Health and added to existing bets and established a new position during the third quarter, according to regulatory filings.  Longtime investor Glenview Capital Management bought 2.8 million CVS shares during the third quarter, increasing its stake by 31%.  Sachem Head Capital Management, which built its CVS position during the second quarter, bought over 1 million shares during the three months ended on Sept. 30, increasing its position by 44%.",
      "url": "https://finnhub.io/api/news?id=c15ccfae87708e4c82ca840904059eaa30f03dbdf3e441738fb17e7e7a9be6b1"
    }
  },
  {
    "ts": null,
    "headline": "CVS Health Corp. stock outperforms competitors on strong trading day",
    "summary": "CVS Health Corp. stock outperforms competitors on strong trading day",
    "url": "https://finnhub.io/api/news?id=1f48eccf45b2dcb15bdd4e9ba8d0c4cf390dd6ba397b5c8dab62f7bc01e1e1e8",
    "source": "MarketWatch",
    "provider": "finnhub",
    "raw": {
      "category": "company",
      "datetime": 1731602880,
      "headline": "CVS Health Corp. stock outperforms competitors on strong trading day",
      "id": 131420194,
      "image": "",
      "related": "CVS",
      "source": "MarketWatch",
      "summary": "CVS Health Corp. stock outperforms competitors on strong trading day",
      "url": "https://finnhub.io/api/news?id=1f48eccf45b2dcb15bdd4e9ba8d0c4cf390dd6ba397b5c8dab62f7bc01e1e1e8"
    }
  },
  {
    "ts": null,
    "headline": "Amazon Will Start Selling Cheap Hair-Loss Drugs. It’s a Huge Threat for This Stock.",
    "summary": "Amazon Will Start Selling Cheap Hair-Loss Drugs. It’s a Huge Threat for This Stock.",
    "url": "https://finnhub.io/api/news?id=39fecdee6c481ff01b0239d9d6bea29c858d71990b8699001e360a55ea7adcd6",
    "source": "MarketWatch",
    "provider": "finnhub",
    "raw": {
      "category": "company",
      "datetime": 1731593460,
      "headline": "Amazon Will Start Selling Cheap Hair-Loss Drugs. It’s a Huge Threat for This Stock.",
      "id": 131413108,
      "image": "",
      "related": "CVS",
      "source": "MarketWatch",
      "summary": "Amazon Will Start Selling Cheap Hair-Loss Drugs. It’s a Huge Threat for This Stock.",
      "url": "https://finnhub.io/api/news?id=39fecdee6c481ff01b0239d9d6bea29c858d71990b8699001e360a55ea7adcd6"
    }
  },
  {
    "ts": null,
    "headline": "2 Beaten-Down Dividend Stocks to Buy and Hold",
    "summary": "They're down, but they aren't out, at least not in the eyes of patient investors.",
    "url": "https://finnhub.io/api/news?id=5aae0cf661a8b73fdf05f1e5ffd806db4dcb80ff52437c61e57f0a29336b748a",
    "source": "Yahoo",
    "provider": "finnhub",
    "raw": {
      "category": "company",
      "datetime": 1731589200,
      "headline": "2 Beaten-Down Dividend Stocks to Buy and Hold",
      "id": 131348698,
      "image": "https://g.foolcdn.com/editorial/images/796833/pharmacist-talking-to-patient.jpg",
      "related": "CVS",
      "source": "Yahoo",
      "summary": "They're down, but they aren't out, at least not in the eyes of patient investors.",
      "url": "https://finnhub.io/api/news?id=5aae0cf661a8b73fdf05f1e5ffd806db4dcb80ff52437c61e57f0a29336b748a"
    }
  }
]